Company & Sponsor Intelligence
Haukeland University Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting2
Completed2
Countries1
Therapeutic footprint
adhdparkinsons
Indexed studies
NCT03816020NAD-supplementation in Drug naïve Parkinson's Disease
parkinsons · NorwayNA
parkinsons · NorwayNA
NCT06299189A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
adhd · NorwayNA
adhd · NorwayNA
NCT05546567NOPARK Open Label Extension Study
parkinsons · NorwayNA
parkinsons · NorwayNA
NCT05589766N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease
parkinsons · NorwayPHASE2
parkinsons · NorwayPHASE2
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →